1. Home
  2. IMMP vs TG Comparison

IMMP vs TG Comparison

Compare IMMP & TG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMMP
  • TG
  • Stock Information
  • Founded
  • IMMP 1987
  • TG 1988
  • Country
  • IMMP Australia
  • TG United States
  • Employees
  • IMMP N/A
  • TG N/A
  • Industry
  • IMMP Biotechnology: Pharmaceutical Preparations
  • TG Metal Fabrications
  • Sector
  • IMMP Health Care
  • TG Industrials
  • Exchange
  • IMMP Nasdaq
  • TG Nasdaq
  • Market Cap
  • IMMP 304.0M
  • TG 267.5M
  • IPO Year
  • IMMP N/A
  • TG 1989
  • Fundamental
  • Price
  • IMMP $1.93
  • TG $7.95
  • Analyst Decision
  • IMMP Buy
  • TG
  • Analyst Count
  • IMMP 2
  • TG 0
  • Target Price
  • IMMP $8.50
  • TG N/A
  • AVG Volume (30 Days)
  • IMMP 98.7K
  • TG 120.7K
  • Earning Date
  • IMMP 02-27-2025
  • TG 11-08-2024
  • Dividend Yield
  • IMMP N/A
  • TG N/A
  • EPS Growth
  • IMMP N/A
  • TG N/A
  • EPS
  • IMMP N/A
  • TG N/A
  • Revenue
  • IMMP $2,563,302.00
  • TG $717,366,000.00
  • Revenue This Year
  • IMMP N/A
  • TG N/A
  • Revenue Next Year
  • IMMP $47.79
  • TG N/A
  • P/E Ratio
  • IMMP N/A
  • TG N/A
  • Revenue Growth
  • IMMP 9.59
  • TG N/A
  • 52 Week Low
  • IMMP $1.66
  • TG $3.98
  • 52 Week High
  • IMMP $3.34
  • TG $9.22
  • Technical
  • Relative Strength Index (RSI)
  • IMMP 42.28
  • TG 57.20
  • Support Level
  • IMMP $2.00
  • TG $7.49
  • Resistance Level
  • IMMP $2.05
  • TG $8.03
  • Average True Range (ATR)
  • IMMP 0.09
  • TG 0.30
  • MACD
  • IMMP -0.02
  • TG 0.02
  • Stochastic Oscillator
  • IMMP 8.33
  • TG 80.92

About IMMP Immutep Limited

Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.

About TG Tredegar Corporation

Tredegar Corp through its subsidiaries engaged in the manufacture of Polyethylene Plastic films, Polyester Films, and Aluminum Extrusions. Polyethylene Plastic films manufacture plastic films, elastics and laminate materials which are utilized in personal care materials, surface protection films, and specialty and optical lighting applications. It operates through PE Films, Flexible Packaging Films, and Aluminum Extrusions segments. Aluminum Extrusions generates the majority of revenue and produces high-quality, soft-alloy, and medium-strength aluminum use for building and construction, automotive, consumer durables, machinery and equipment, electrical, and distribution markets. It generates revenue from the United States, Asia, and Brazil.

Share on Social Networks: